Form 4: Hims & Hers Chief Policy Officer Sells Shares
Insider Transaction Report
Hims & Hers Health, Inc. Chief Policy Officer Deborah M. Autor sold 7,054 shares of Class A Common Stock for $36.71 per share.
Summary
- Deborah M. Autor, Chief Policy Officer and Director of Hims & Hers Health, Inc. (HIMS), disposed of 7,054 shares of Class A Common Stock.
- The transaction occurred on December 17, 2025, at a price of $36.71 per share.
- Following this sale, Ms. Autor beneficially owns 6,175 shares of Class A Common Stock.
- The sale was executed pursuant to a Rule 10b5-1 trading plan, which was adopted by Ms. Autor on August 11, 2025.
Sentiment
Score: 5
Explanation: The sentiment is neutral. While an insider sale can sometimes be viewed negatively, the transaction was executed under a pre-arranged 10b5-1 plan, which indicates it was not based on new, non-public information, thus mitigating potential negative interpretations.
Negatives
- An insider sale of 7,054 shares by a Chief Policy Officer and Director, while executed under a pre-arranged 10b5-1 plan, could be perceived by some investors as a signal, though the pre-planned nature mitigates immediate concerns about market timing.
Future Outlook
This filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.
Industry Context
This insider transaction is specific to Hims & Hers Health, Inc. and its Chief Policy Officer and does not directly reflect broader industry trends or competitive dynamics.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Trading Plan Adoption | The sale was conducted under a Rule 10b5-1 trading plan adopted on August 11, 2025, which allows insiders to pre-arrange sales of company stock to avoid accusations of insider trading. | 08/11/2025 | Enhances transparency and provides an affirmative defense against insider trading allegations for pre-planned transactions. |
Stakeholder Impact
- Shareholders may note the sale of shares by a key executive, which could lead to minor sentiment shifts, although the 10b5-1 plan typically reduces concerns about the timing of the sale.
Key Dates
| Date | Description |
|---|---|
| 08/11/2025 | Date Rule 10b5-1 trading plan was adopted by Deborah M. Autor. |
| 12/17/2025 | Date of transaction where Deborah M. Autor sold Class A Common Stock. |
| 12/18/2025 | Date the Form 4 was signed. |
Keywords
Hims & Hers Health, HIMS, Insider Trading, Stock Sale, Form 4, Deborah Autor, Chief Policy Officer, 10b5-1 Plan
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.